Individual with academic appointment who is a Principal Investigator of peer reviewed funded, vaccine-related research and author of publications in leading scientific journals, or investigator who is involved in NIH sponsored clinical trials and has active participation in programmatic activities.
Investigator with academic appointment and active involvement in vaccine research
Clinician with academic appointment who has demonstrated participation in patient based JVC research; and commitment to Jefferson Vaccine Center mission.
Individual who is involved in supporting the Jefferson Vaccine Center mission.
Individual who has made an outstanding contribution to the mission of the Jefferson Vaccine Center.
Community member who is keenly interested in supporting the mission of the Jefferson Vaccine Center.
In the News
New Funding for JVC Members
Dr. McGettigan, was awarded a four-year $1.5 million R01 grant from the NIH to extend his exciting work on the development of a novel, safe, and effective rabies virus vaccine.
A Team of Researchers from Fox Chase, Jefferson and Penn State Receive NIAID Grant for Viral Control. Both Dr. Luis Sigal and Dr. Eisenlohr are members of the JVC. The team to receive a total of approximately $2 million each year for the next five years. For more information ...
Dr. David Abraham received a five year R01 grant to study the development of a recombinant vaccine against human onchocerciasis.